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Abstract
Background: Dystroglycanopathies are a group of inherited disorders characterized by vast clinical and genetic
heterogeneity and caused by abnormal functioning of the ECM receptor dystroglycan (Dg). Remarkably, among
many cases of diagnosed dystroglycanopathies, only a small fraction can be linked directly to mutations in Dg or its
regulatory enzymes, implying the involvement of other, not-yet-characterized, Dg-regulating factors. To advance
disease diagnostics and develop new treatment strategies, new approaches to find dystroglycanopathy-related
factors should be considered. The Dg complex is highly evolutionarily conserved; therefore, model genetic
organisms provide excellent systems to address this challenge. In particular, Drosophila is amenable to experiments
not feasible in any other system, allowing original insights about the functional interactors of the Dg complex.
Methods: To identify new players contributing to dystroglycanopathies, we used Drosophila as a genetic muscular
dystrophy model. Using mass spectrometry, we searched for muscle-specific Dg interactors. Next, in silico analyses
allowed us to determine their association with diseases and pathological conditions in humans. Using
immunohistochemical, biochemical, and genetic interaction approaches followed by the detailed analysis of the
muscle tissue architecture, we verified Dg interaction with some of the discovered factors. Analyses of mouse
muscles and myocytes were used to test if interactions are conserved in vertebrates.
Results: The muscle-specific Dg complexome revealed novel components that influence the efficiency of Dg
function in the muscles. We identified the closest human homologs for Dg-interacting partners, determined their
significant enrichment in disease-associations, and verified some of the newly identified Dg interactions. We found
that Dg associates with two components of the mechanosignaling Hippo pathway: the WW domain-containing
proteins Kibra and Yorkie. Importantly, this conserved interaction manages adult muscle size and integrity.
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Conclusions: The results presented in this study provide a new list of muscle-specific Dg interactors, further
analysis of which could aid not only in the diagnosis of muscular dystrophies, but also in the development of new
therapeutics. To regulate muscle fitness during aging and disease, Dg associates with Kibra and Yorkie and acts as a
transmembrane Hippo signaling receptor that transmits extracellular information to intracellular signaling cascades,
regulating muscle gene expression.
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Background
In higher organisms, the muscles express specialized
protein complexes, e.g., the dystrophin glycoprotein
complex (DGC, Fig. 1a), which permits transmission of
forces from the extracellular matrix (ECM) to the inside
of the cell and reduces mechanical stress placed on the
plasma membrane, thus shielding the fragile sarco-
lemma. DGC dysfunctions cause the development of the
pathological states commonly called muscular dystro-
phies (MDs) in humans, which is a large group of gen-
etic diseases associated with muscle weakening and loss.
Among the DGC-associated muscular dystrophies are
Duchenne/Becker muscular dystrophies (DMD/BMD),
resulting from mutations in the cytoplasmic protein dys-
trophin that connects actin cytoskeleton to the muscle
membrane; limb-girdle muscular dystrophies (LGMDs),
caused by the dysfunction of the membrane-associated
dystroglycan and sarcoglycan multiprotein complexes;
and congenital muscular dystrophies (CMDs), triggered
by the deregulation of dystroglycan and the ECM pro-
tein laminin (Fig. 1a). Due to the high rates of these
deadly diseases, intensive research has been directed to-
wards understanding the role of the DGC in providing
mechanical stability to the muscle sarcolemma. How-
ever, it has been shown that the DGC not only offers
strength to the muscle but also is capable of mediating
intra- and extracellular signaling [1–3].
Since dystroglycanopathies encompass significant clin-
ical, pathological, and genetic heterogeneity, their proper
diagnosis is challenging. For example, primary dystrogly-
canopathies result from a mutation in the Dg gene per
se (DAG1 in vertebrates), while deficiencies in 17 genes
encoding the enzymes involved in Dg glycosylation have
been identified and associated with secondary dystrogly-
canopathies [4, 5]. Currently, the diagnosis of these fatal
neuromuscular disorders is implemented on the basis of
(i) clinical and biological features associated with limb-
girdle muscular dystrophy, lissencephaly type II, and
congenital muscle dystrophy and (ii) elevated levels of a
sensitive parameter of muscle damage, creatine kinase.
These steps are followed by (iii) gene sequencing to
identify mutations in the abovementioned 18 genes [4–
7]. Despite recent advances, the efficiency of accurate
genetic and molecular diagnoses is rather low—only 36%
in children and 22% in adults [4, 8]. It was experimen-
tally validated that in the sarcolemma of muscle fibers,
Dg arranges various protein complexes even in the ab-
sence of both dystrophin and utrophin [9], supporting
the idea about a broader role for Dg, apart from being a
core DGC component. To advance the disease diagnos-
tics and develop new treatment strategies, it is essential
to identify novel components that influence the effi-
ciency of Dg function in the muscles. In addition to gen-
etic causes, multiple other internal and external stress
factors trigger muscle wasting; for example, aging is
often associated with sarcopenia, nutritional deficit, and
cancer leading to cachexia, while sleep deprivation and
hormonal imbalance cause muscle atrophy [10–12]. Un-
fortunately, nutritional supplements and physical exer-
cises have only very limited abilities to ameliorate these
conditions and restore muscle mass and function.
Therefore, a search for novel components modulating
muscle maintenance under stress is important for im-
proving active life expectancy in older people or cancer
patients.
Due to the fact that the Dg complex is highly evolu-
tionarily conserved, model genetic organisms including
Drosophila provide an excellent system to dissect the
functions of Dg itself and get insight into its cellular life-
cycle and involvement in different signaling pathways.
Previously, we have shown that Drosophila can serve as
a great system to study MDs, since Dg deficiency leads
to a range of muscular and neuronal dysfunctions [13].
In addition, Dg gene structure is remarkably conserved
[14]. Drosophila Dg has functions distinct from Dys and,
apart from its role in muscle maintenance, is involved in
the regulation of energy homeostasis, photoreceptor dif-
ferentiation, neuromuscular junction establishment, and
cellular polarity [15–20]. Precise control of Dg expres-
sion during development is critical; its elevation can be
as dramatic as its deficiency. At the post-transcriptional
level, Dg is subject to miRNA-based regulation in vari-
ous tissues [3, 21]. Moreover, the DGC can regulate the
expression of miRNA genes, in particular via a Dg-Dys-
Syn1 signaling cascade [3, 22]. The DGC-dependent ef-
fect on the miRNA profile is linked to stress, and there
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is a correlation between miRNAs regulated by either
DGC or stress conditions [22]. Furthermore, stress
causes muscle wasting even in healthy Drosophila ani-
mals, while DGC-mutant muscles are already compro-
mised and more susceptible to stress [18]. Together,
these data imply that the transmembrane protein Dg has
a potential role of sensing extracellular stimuli
(stressors) and transmitting signals to the cell, governing
cellular stress responses. With regard to the muscle tis-
sue that continuously withstands vigor of contractions, it
is likely that Dg not only serves as a physical anchor be-
tween the ECM and the cytoskeleton, but also plays a
role in transducing mechanical stresses sensed from the
ECM to the intracellular signaling pathways controlling
gene expression. This function is extremely important,
since throughout life, muscle cells are constantly ex-
posed to mechanical forces. Although these forces are
important regulators of normal cell function, muscle cell
membrane rupture occurs frequently even under physio-
logical conditions [23], which is most prevalent in the
skeletal and cardiac muscles. It results in the influx of
extracellular Ca2+ and the loss of cytoplasmic ingredi-
ents. This disturbs the maintenance of the balance be-
tween the cytoplasm and the extracellular space and
causes contraction defects and/or cell death [24, 25].
Moreover, in muscle cells, mechanical forces induce a
tension-driven mechanism for the self-organization of
myofibrils during development [26]. One of the most
famous mechanotransducing pathways is the evolution-
arily conserved Hippo signaling pathway. Yap (Yes-asso-
ciated protein), a mammalian homolog of Drosophila
Yorkie (Yki), is a nuclear factor of the Hippo kinase sig-
nal transduction pathway that relays on mechanical sig-
nals exerted by the ECM stiffness, cell geometry, and
cytoskeletal tension to mediate cellular mechanore-
sponses [27]. The key to this pathway is a kinase cascade
in which Hippo phosphorylates and activates Warts,
which in turn phosphorylates and inactivates Yap/Yki
[28]. Yap/Yki together with TEAD/TEF transcription
factors regulate the expression of genes that promote
cell proliferation, prevent apoptosis, or control innate
immunity [29–31]. Importantly in mammalian adult
skeletal muscles, Yap has been shown to positively regu-
late skeletal muscle mass and protein synthesis following
injury and upon neurogenic muscle atrophy [32] and
have differential expression in healthy and dystrophic
muscles [33, 34]. Recent studies revealed the connection
between the DGC and the Hippo pathway in the mouse
heart; however, how this interaction influences Hippo
and DGC signaling is not understood. For example, in
the developing, proliferative mouse heart, Yap regulates
the expression of the Sgcd gene encoding sarcoglycan,
which is a part of the DGC [35]; while in the adult heart,
Dg (DAG1) directly binds and sequesters phosphorylated
Yap to inhibit cardiomyocyte proliferation [36]. While
the previous data strongly support the idea that the key
DGC component, Dg, plays a role in mechanotransduc-
tion and clearly demonstrate that Hippo signaling is a
key pathway responding to mechanical stress, the func-
tional link between the DGC and Hippo kinase signaling
in the maintenance of skeletal muscle tissue integrity
and architecture remains unclear.
In this study, we analyzed the Drosophila Dg interac-
tome to identify novel muscle-specific components asso-
ciated with the DGC using mass spectrometry. We
experimentally validated the interaction and co-
localization of Dg with several identified candidates. In
particular, we verified Dg interactions in different types
of larval and adult muscles with LamininA subunits and
several other muscle cytoskeleton proteins. Importantly,
we found Hippo protein kinase signaling pathway com-
ponents to physically and genetically interact with Dg in
(See figure on previous page.)
Fig. 1 Identification of dystroglycan-associated proteins. a Schematic of Drosophila dystrophin glycoprotein complex (DGC). The transmembrane
protein dystroglycan (Dg) is a major component of the DGC. Its C-terminal end binds the cytoplasmic protein dystrophin (Dys), while the heavily
glycosylated N-terminus is associated with extracellular matrix (ECM) proteins. In humans, perturbed DGC function results in various types of
neuromuscular disorders such as congenital muscular dystrophy (CMD), limb-girdle muscular dystrophy (LGMD), and Duchenne/Becker muscular
dystrophy (DMD/BMD). b The pipeline used to identify muscle-specific Dg-associated proteins. Firstly, we generated transgenic animals
expressing in the muscle tissue the full-length Dg tagged by the GFP at the C-terminal end (Mhc-Gal4/+, UAS Dg::GFP/+, abbreviated Mhc>Dg).
Secondly, tissue lysates were subjected to co-immunoprecipitation procedure with GFP-Trap beads. Thirdly, immunoprecipitated Dg protein
complexes were analyzed by mass spectrometry in order to identify Dg-interacting proteins. Lastly, revealed Dg-associated components were
bioinformatically analyzed. c Coomassie Blue-stained gel confirms increased protein levels in the samples with muscle-specific Dg overexpression.
Experiments were performed in triplicate. As a control, the driver line crossed to a wild-type line was used (Mhc-Gal4/OregonR, abbreviated Mhc>/
+). d Schematic of muscle cell with subcellular compartments (plasma membrane, cytoskeleton, mitochondria, cytoplasmic vesicles, nucleus,
endoplasmic reticulum, and Golgi apparatus). The scheme was created with the SERVIER Medical Art. Subcellular localization of the identified Dg-
associated proteins. e Protein association network for Dg-interacting proteins clustered in functional groups, among which are structural
components of the basal lamina, proteins with functions in muscle cell cytoskeleton, cellular transport regulators, mitochondria-associated
proteins, factors regulating protein biosynthesis and degradation, cellular metabolism, nucleosome components, and proteins from the Hippo
signaling pathway. Nodes represent proteins, lines and dashed lines connect associated proteins, and line thickness shows the confidence of
association. Markov clustering algorithm identifies several protein complexes (thick blue lines) within basal lamina, cytoskeleton, protein
degradation, mitochondria, and nucleosome groups
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adult fast-twitch oxidative muscles and revealed the re-
quirement for Hippo signaling in control of muscle size
and integrity during aging. Based on our findings, we
propose that Dg associates with Kibra (Kbr) and Yki in
adult muscles and possibly acts as a mechanosensing re-
ceptor for the Hippo signaling pathway, modulating its
function. Thus, our data show a conserved role of Dg in
mediating Hippo signaling in muscle cells, which man-




Drosophila stocks and crosses were maintained at stand-
ard corn meal, yeast, glucose agar medium at 25 °C
under 12-h:12-h light:dark cycles.
To co-immunoprecipitate Dg from the muscle tissue, the
transgenic animals bearing C-terminally GFP-tagged Dg
construct UAS-Dg::GFP [17] were crossed to Mhc-Gal4 (BL
#55132) driver line allowing for the muscle-specific Dg ex-
pression, which resulted in sixfold increase in Dg levels (see
Additional file 1: Data S1). As a control, the driver line
crossed to a wild-type line was used (Mhc-Gal4/OregonR,
abbreviatedMhc>/+) or to UAS-CD8::GFP (BL #5137).
To address the co-localization of Dg with other identi-
fied muscle components, the collection of strains ex-
pressing GFP-tagged proteins [37] was used: LanA-GFP
(VDRC #318155), LanB1::GFP (VDRC #318180), hts::
GFP (VDRC #318163), wupA::GFP (VDRC #318278), and
yki::GFP (VDRC #318237).
To downregulate or overexpress the studied proteins
in the muscles, the following transgenic constructs were
used: UAS-dsDg30A (DgRNAi) [13], UAS-ykiRNAi (ykiR-
NAi, BL34067), UAS-kbrRNAi (kbrRNAi, BL28683), UAS-
yki (BL28816), and UAS-kbr (VDRC 100705).
To identify genetic interactions of Dg with Hippo
pathway components in the wings and muscles, the Dg
loss-of-function mutants DgO55, DgO43, and/or DgO86
[38] were crossed with the following Hippo pathway mu-
tants: FRT82B kbrdel (483-5860)/TM6 (kbrdel), FRT42D
hpo42-47/SM6 (gifts from Wu-Min Deng), and FRT42D
ykiB5/CyO (a gift from DuoJia Pan). The progeny hetero-
zygous for Dg and a tested mutant allele were collected
for indirect flight muscle (IFM) analyses.
For muscle analysis, several conditions were applied.
Hatched adults, kept for 7 days at normal laboratory
conditions, were considered as young animals, while
adults maintained for 28–30 days at the same conditions
were reflected as aged.
Co-immunoprecipitation and western blot analysis in
Drosophila
Whole lysates for general co-immunoprecipitation (co-
IP) were prepared from approximately 1-week-old flies
that were homogenized with VWR Disposable Pellet
Mixers and lysed in RIPA buffer containing 50mM Tris-
HCl (pH 7.5), 125 mM NaCl, 5% glycerol, 0.5% NP40,
0.25% Na-deoxycholate, 1.5 mM MgCl2, 1 mM dithio-
threitol, 25 mM NaF, 1 mM Na3VO4, 1 mM EDTA, 2
mM EGTA, and protease inhibitors. Samples were then
centrifuged at 15,000g for 15 min at 4 °C, and then 1.3
mg of supernatants was immunoprecipitated with GFP-
Trap beads (ChromoTek) following the manufacturer’s
instructions. Four percent of total protein extracts used
for immunoprecipitation were loaded as input. The pres-
ence of immunocomplexes was analyzed via SDS-PAGE
and western blotting as described in [39]. The following
antibodies were used: rabbit anti-Kibra (1:1000, a gift
from Wu-Min Deng), rabbit anti-Laminin (1:1000,
Abcam ab47651), mouse anti-Hts (also called Adducin,
1:1000, DSHB), and chicken anti-GFP (1:5000, Abcam
ab13970).
For the co-IP coupled to mass spectrometry, whole ly-
sates were prepared from 1-week-old flies harvested by
snap freezing in liquid nitrogen. Three biological repli-
cates of 3–4 mg of both control (Mhc-Gal4/+) and ex-
perimental flies (Mhc-Gal4/UAS-Dg::GFP) were
homogenized and lysed by grinding in 3 ml of the above-
mentioned RIPA buffer in a mortar with pestle using li-
quid nitrogen. Lysates were cleared by two centrifuging
steps once for 15 min and once for 10 min at 15000g at
4 °C. Next, 36 mg of protein extract was added to 26 μl
of GFP-Trap beads in 2 × 1.5 ml micro-centrifuge tubes
and incubated rotating at 4 °C overnight. To collect the
beads, lysates were centrifuged at 2500g for 2 min at
4 °C. The beads were washed six times with ice-cold
RIPA lysis buffer and were finally eluted with 40 μl of
warm 2× sample buffer (NuPAGE LDS Sample Buffer,
Novex). The eluates were analyzed by mass spectrometry
after SDS-PAGE.
Coomassie Brilliant Blue staining
The Coomassie Brilliant Blue (CBB) staining was per-
formed as previously described [40]. In brief, CBB G-250
is dissolved in double-distilled water in a concentration
of 60–80mg/l, and 35mM HCl is added as the only
other compound in the staining solution. The gel from
SDS-PAGE was rinsed with double-distilled water and
incubated in CBB staining solution overnight at room
temperature with gentle shaking. Next, the stained gel
was distained by washing with double-distilled water.
Gel electrophoresis, in-gel digestion, and mass
spectrometry (LC-MS/MS)
Proteins were separated by one-dimensional SDS-PAGE
(4–12% NuPAGE Bis-Tris Gel, Invitrogen) and stained
with Coomassie Blue G-250 (Fluka). The complete gel
lanes were cut into 23 equally sized slices. Proteins were
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digested as described previously [41]. Briefly, proteins
were reduced with 10mM DTT for 50min at 50 °C, after-
wards alkylated with 55mM iodoacetamide for 20min at
26 °C. In-gel digestion was performed with Lys-C (Roche
Applied Science) overnight. Extracted peptides from gel
slices were loaded onto the in-house packed C18 trap col-
umn (ReproSil-Pur 120 C18-AQ, 5 μm, Dr. Maisch
GmbH; 20 × 0.100mm) at a flow rate of 5 μl/min loading
buffer (2% acetonitrile, 0.1% formic acid). Peptides were
separated on the analytical column (ReproSil-Pur 120
C18-AQ, 3 μm, Dr. Maisch GmbH; 200 × 0.050mm,
packed in-house into a PF360-75-15-N picofrit capillary,
New Objective) with a 90-min linear gradient from 5 to
40% acetonitrile containing 0.1% formic acid at a flow rate
of 300 nL min−1 using nanoflow liquid chromatography
system (EASY n-LC 1000, Thermo Scientific) coupled to
hybrid quadrupole-Orbitrap (Q Exactive, Thermo Scien-
tific). The mass spectrometer was operated in data-
dependent acquisition mode where survey scans acquired
from m/z 350–1600 in the Orbitrap at resolution settings
of 70,000 FWHM at m/z 200 at a target value of 1 × 10e6.
Up to 15 most abundant precursor ions with charge states
2+ or more were sequentially isolated and fragmented
with higher collision-induced dissociation (HCD) with
normalized collision energy of 28. Dynamic exclusion was
set to 18 s to avoid repeating the sequencing of the pep-
tides. It is important to stress that current mass spectrom-
etry techniques are quite limited; depending on the
method and tissue only 10–30% of all known Drosophila
proteins can be detected, most of which are highly
expressed, housekeeping genes [42]. The muscle in par-
ticular is a highly specialized tissue that expresses very
high levels of distinct structural proteins, which makes it
challenging for mass spectrometry analysis. For example,
in our experiment, myosin heavy chain represented ~ 30%
of all hits, as it is the most highly expressed muscle pro-
tein (Additional file 1: Data S1). This could have prevented
the identification of some proteins that are expressed at
significantly lower levels.
Mass spectrometry data analysis
The generated raw mass spectrometry files were ana-
lyzed with MaxQuant software [43] (version 1.3.0.5,
using Andromeda search engine) against UniProtKB D.
melanogaster database containing 18,826 entries (down-
loaded in April 2013) supplemented with common con-
taminants and concatenated with the reverse sequences
of all entries. The following Andromeda search parame-
ters were set: carbamidomethylation of cysteines as a
fixed modification, oxidation of methionine and N-
terminal acetylation as a variable modification, and Lys-
C specificity with no proline restriction and up to two
missed cleavages. The MS survey scan mass tolerance
was 7 ppm and for MS/MS 20 ppm. For protein
identification, minimum of 5 amino acids per identified
peptide and at least 1 peptide per protein group were re-
quired. The false discovery rate was set to 1% at both
peptide and protein levels. “Re-quantify” was enabled,
and “keep low scoring versions of identified peptides”
was disabled. The mass spectrometry analysis detected
1506 proteins in total (Additional file 1: Data S1). Aver-
age fold change and standard deviation between the con-
trol (Mhc-Gal4/OregonR) and the experiment (GFP-
tagged muscle-driven Dg, Mhc-Gal4/UAS Dg::GFP) are
determined from 3 independent biological replicates.
Two-tailed Student’s t test was applied for statistical
analysis. The numbers in the table correspond to the ab-
solute numbers of reads per protein. Proteins with statis-
tically significant ≥ 2-fold increase in comparison with
control were considered as Dg-interacting proteins. Such
analysis allowed identifying 83 muscle-specific Dg-
interacting components (Additional file 1: Data S1).
Note that some of the proteins, such as Zipper (myosin
heavy chain) and WupA (troponin), were detected as
separate isoforms (outlined by grayish in the Add-
itional file 1: Data S1), Dg per se is marked by blue.
Bioinformatical analyses
To arrange identified interactors in the functional protein-
association network, we used STRING v10 database [44],
with medium confidence score (0.04), and prediction
methods that included neighborhood, gene fusion, co-
occurrence, co-expression, experiments, databases, and text
mining. The network is presented in a “confidence” view,
where the thickness of lines connecting the nodes repre-
sents the confidence of association. Lines connect compo-
nents clustered by MCL (Markov clustering algorithm) into
protein complexes. Dashed lines show associations between
components that do not form protein complexes. For Gene
Ontology enrichment analysis, STRING and Gene Ontol-
ogy Consortium [45] (http://geneontology.org) were used.
To assign protein cellular localization and molecular func-
tion and to find human orthologs, the FB2016_02 release
FlyBase was applied. To search for the human disease asso-
ciation, http://www.flyrnai.org [46] and http://www.gene-
cards.org were used. For human disease association
enrichment analysis, the entry of 77 human genes (ortho-
logs of identified Dg-interacting components) was exam-
ined with http://ctdbase.org/tools (Disease) tool. For
protein domain structure analysis, SMART (http://smart.
embl-heidelberg.de) was used. For WW domain sequence
alignment, PRALINE multiple sequence alignment source
(http://www.ibi.vu.nl) was utilized.
Histology and immunohistochemistry of Drosophila
muscles
For the analysis of adult indirect flight muscle (IFM)
morphology, 7-μm paraffin-embedded sections were cut
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from fly thoraces. To prepare Drosophila muscle sec-
tions, the fly bodies were immobilized in the collars in
the required orientation and fixed in Carnoy fixative so-
lution (6:3:1 ethanol to chloroform to acetic acid) at 4 °C
overnight. Tissue dehydration and embedding in paraffin
were performed as described previously [47]. Histo-
logical sections were prepared using a Hyrax M25
(Zeiss) microtome and stained with hematoxylin and
eosin as described previously [13]. All chemicals for
these procedures were obtained from Sigma Aldrich.
Larval body wall muscles were prepared as previously
described [48]. Adult ovaries and guts were rapidly dis-
sected in PBS and fixed in 4% formaldehyde (Poly-
sciences, Inc.) for 15 min. Staining was performed as
described [49]. Samples were mounted in 70% glycerol.
Antibodies for Drosophila immunohistochemistry
The following are the antibodies for Drosophila immu-
nohistochemistry: polyclonal rabbit anti-Dg 1:1000 [50],
anti-Kibra 1:1000 (gifts from Wu-Min Deng), and anti-
gamma 1 (LanB2) 1:1000 (Abcam, ab47651); chicken
anti-GFP 1:2000 (Invitrogen); monoclonal mouse anti-
Hts (also called Adducin, 1:20, DSHB); and Alexa 488,
568, or 633 goat anti-mouse, anti-rabbit, anti-chicken (1:
500, Molecular Probes). To visualize nucleoli, a 10-min-
long incubation with 1× DAPI (Sigma Aldrich) in PBS
was performed.
Fractionation of mouse muscle tissue
All animal experiments were consistent with the Israel
Council on Animal Experiments guidelines and the In-
stitutional Regulations of Animal Care and Use. Special-
ized personnel provided mouse care in the institutional
animal facility. To obtain whole-cell extracts, mouse tibi-
alis anterior muscles (50 mg each) were homogenized as
previously described [51]. Briefly, following
homogenization in lysis buffer (20 mM Tris pH 7.2, 5
mM EGTA, 100 mM KCl, 1% Triton X-100, 1 mM
PMSF, 3 mM benzamidine, 10 μg/ml Leupeptin, 50 mM
NaF, and 2.7 mM Sodium OrthoVanadate), the homoge-
nates were centrifuged at 6000 × g for 20 min at 4 °C,
and the supernatant (containing whole-cell extract) was
collected and stored at − 80 °C.
Immunoprecipitation from mouse muscle extracts
For β-dystroglycan immunoprecipitation, a specific anti-
body was added to whole-cell extracts (control sample
contained mouse IgG), samples were incubated over-
night at 4 °C, and protein A/G agarose was then added
for 4 h. To remove nonspecific or weakly associated pro-
teins, the resulting precipitates were washed extensively
with ten bed volumes of each of the following buffers:
buffer A (50 mM Tris-HCl pH 8, 500mM NaCl, 0.1%
SDS, 0.1% Triton, 5 mM EDTA), buffer B (50 mM Tris-
HCl pH 8, 150 mM NaCl, 0.1% SDS, 0.1% Triton, 5 mM
EDTA), and buffer C (50 mM Tris-HCl pH 8, 0.1% Tri-
ton, 5 mM EDTA). Protein precipitates were eluted in
protein loading buffer containing 50 mM DTT and were
analyzed by SDS-PAGE and immunoblotting-specific
antibodies as described [51].
Antibodies
The β-dystroglycan antibody (used for immunoprecipita-
tion from mouse muscle extracts) developed by Glenn E.
Morris (RJAH Orthopaedic Hospital, Oswestry, UK) was
obtained from the Developmental Studies Hybridoma
Bank, created by the NICHD of the NIH and maintained
at The University of Iowa, Department of Biology, Iowa
City, IA 52242 (MANDAG2, clone 7D11, lot# S1ea).
The Kibra antibody was from Abcam (ab216508).
Mouse myotubes differentiation
For immunofluorescence studies, mouse C2C12 myo-
blasts (ATCC) were seeded on poly-L-lysine-coated glass
coverslips and cultured for 2 days in growth medium
(GM), consisting of complete Dulbecco’s modified Ea-
gle’s medium (DMEM) (Invitrogen) supplemented with
10% fetal bovine serum. At confluency, GM was replaced
by differentiation medium (DM, DMEM plus 5% horse
serum) and cells were grown for additional 5 days in
DM. Cells were washed, fixed, and stained as described
previously [52].
Mouse muscle tissue sections
Mouse muscles were rapidly dissected, placed in dispos-
able vinyl specimen molds (Tissue-Tek Cryomold), filled
with O.C.T. Compound (Tissue-Tek), and frozen in −
60 °C cooler, as previously described [47]. Then, 10-μm-
thick muscle sections were made on Microm HM 560
Cryostat (Thermo Scientific) and preserved at − 20 °C
freezer till immunostaining procedure.
Antibodies for mouse immunohistochemistry
To detect Dg, the following antibody was used: goat
anti-DAG1 (1:100, Abcam, ab136665). To detect Kibra,
the following antibody was used: rabbit anti-Kibra (1:
100, Abcam, ab216508). Donkey anti-goat Alexa 488 (1:
500, Invitrogen, A32814) and goat anti-rabbit Alexa 568
(1:500, Invitrogen, A11011) were used as secondary
antibodies.
Microscopy and image analyses
Images of larval body wall muscles and ovarian and di-
gestive system muscles were obtained using Zeiss
LSM700 confocal laser scanning microscope. Protein ex-
pression patterns and protein co-localizations were ana-
lyzed from confocal images taken in a z-stacks (1-μm
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step). Images were processed with ZEN 2011 and Adobe
Photoshop software.
The analysis of adult muscle sections was performed
using the light microscope Zeiss Axiophot, the Zeiss
AxioCam HRc camera, and the Zen 2011 blue software.
The frequency of muscle degeneration was quantified as
a ratio of degenerated muscles to the total number of
analyzed muscles per genotype. The analyzed IFM sec-
tions were located at a position 200–250 μm to the pos-
terior of the fly thorax.
Cross-sectional areas of all 12 indirect flight muscles were
measured using Metamorph software (example areas are
marked and outlined in the main figure) from images taken
with Zen 2011 blue software. The edges of myofibers were
estimated based on the hematoxylin and eosin staining.
All muscle analyses were performed from three bio-
logical replicates. Two-tailed Student’s t test was applied
for statistics.
Results
Mass spectrometric profiling of the dystroglycan
complexome in adult muscles
Currently, only a subset of diagnosed cases characterized
by similar muscular dystrophy symptoms can be linked
to mutations in known DGC components. This implies
that additional, unknown Dg regulators are involved in
muscular dystrophy development. To reveal new Dg-
interacting partners that form complexes with Dg specif-
ically in the muscle tissue, we took advantage of Dros-
ophila as a recognized model to study muscular
disorders and an exemplary system for molecular genetic
manipulations [13, 18, 20, 21, 53, 54]. We expressed the
C-terminal GFP-tagged version of full-length Dg [17]
with the muscle-specific promoter of the myosin heavy
chain (Mhc) gene and immune-isolated protein com-
plexes from whole lysates of young (7-day-old) adult ani-
mals with further detection of specific Dg-interacting
partners by mass spectrometry (Fig. 1b). To decrease
false-positive detections and obtain reliable data, the ex-
periments were performed in biological triplicates, and
each experiment included its own control (Fig. 1c, Add-
itional file 1: Data S1). As a result of mass spectrometric
profiling of the Dg complexome from adult muscle tis-
sue, we detected Dg protein itself plus 83 proteins that
potentially can be directly or indirectly (via other part-
ners) associated with Dg (Additional file 2: Table S1,
Additional file 1: Data S1). Next, we performed intensive
bioinformatics analyses on the identified proteins,
assigned their subcellular localization and molecular
function (Fig. 1d, e; Additional file 2: Table S1), and
identified significant enrichment in various signaling
pathways (Additional file 2: Table S2). Among the 83
identified Dg-associated proteins (Fig. 1e), bioinformati-
cal analysis reveals 5 ECM components, 6 proteins
associated with the plasma membrane, 16 cytoskeleton
structural constituents, 8 mitochondria-linked factors, 9
nuclear, 21 cytosolic, 5 endoplasmic reticulum-
associated, and 2 cytoplasmic vesicle-linked proteins (the
numbers of identified proteins that are associated with
different subcellular compartments are shown in red
squares, see also Additional file 2: Table S1). Molecular
function and subcellular localization of 20 components
remain unknown. Particularly, in the Dg interactome, we
identified a significant enrichment in 2 metabolic path-
ways: the glutathione metabolism controlling pathway
(p = 0.021) and the oxidative phosphorylation pathway
(p = 0.036; Additional file 2: Table S2). Previously, we re-
ported that Dg loss-of-function mutants have impaired
metabolism [39], and their muscles are particularly sen-
sitive to sugar dietary restriction [18]. Additionally,
among the immune-isolated proteins upon the GFP-
tagged Dg overexpression, we found a key enzyme that
regulates the glycerol metabolic process to guard flight
behavior, glycerophosphate oxidase 1 (Gpo-1) [55].
Moreover, we identified the closest human homolog
for each Dg-interacting partner, searched for their asso-
ciation with diseases and pathological condition(s) in
humans, and distinguished their significant enrichment
in disease associations (Additional file 2: Tables S1 and
S3). Importantly, most of the identified Dg-associated
components are evolutionarily conserved and have hu-
man homologs (Additional file 2: Table S1), the majority
of which are linked to muscular, neuronal, or metabolic
disorders. Interestingly, the human disease association
enrichment analysis (Additional file 2: Table S3) identi-
fied that human homologs of Dg-interacting proteins de-
tected in this study have significantly enriched
associations with cardiovascular, digestive system, and
urogenital diseases. Taking into account that MD pa-
tients often have cardiac dysfunctions [56], markedly dis-
turbed gastrointestinal motor function [57], and urinary
incontinence [58], we are optimistic that further research
on these Dg-associated components will help in reveal-
ing the etiology of these pathologies.
In summary, among the identified Dg-associated proteins,
there are components of the basal lamina, proteins that play
roles in transmembrane transport, cytoskeletal proteins,
lectins, components involved in protein biosynthesis and
degradation, factors that control cellular metabolism, endo-
plasmic reticulum and Golgi apparatus constituents,
mitochondria-associated proteins, components of the nu-
cleosome, and Hippo signaling factors (Fig. 1d, e).
Dg binds extracellular LamininA and cytoskeletal proteins
in Drosophila muscles
Next, we wanted to verify at the tissue level, using west-
ern blotting and immunohistochemistry assays, Dg inter-
action and co-localization with the proteins identified by
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the proteomics approach. Muscles are coated by a layer
of ECM material called the basement membrane (BM).
BM is not only a stationary structure that offers mech-
anical support and physical barrier for the muscle cell, it
also provides a scaffold to orient cells during regener-
ation, plays an active role in myogenesis and synapto-
genesis, and is lately viewed in the context of ECM
intracellular signaling mediated by the membrane-
associated receptors, including Dg. The composition of
BMs is variable; however, it is usually comprised 2
meshwork-forming components, laminins and collagen.
Laminins are a family of heterotrimeric glycoproteins
composed of 3 different chains, α, β, and γ. The long
arm of the laminin is tethered to an ECM receptor, such
as Dg and/or integrins [59]. Mammals contain at least
15 laminin heterotrimers, which are formed through
various combinations of 5α, 4β, and 3γ subunits, while
invertebrates possess only 1–2 laminin heterotrimers.
Four laminin chains are encoded by the Drosophila gen-
ome: α1.2 (encoded by the wing blister, wb gene), α3.5
(encoded by LamininA, LanA gene), β (encoded by
LamininB1, LanB1), and γ (encoded by LamininB2,
LanB2), forming 2 trimers—LamininA (α3.5, β, γ) and
LamininW (α1.2, β, γ) [60, 61]. Our mass spectrometry
detection identified all 3 subunits of LamininA to be co-
purified with Dg from Drosophila muscles (Fig. 2a).
Since the Dg-Laminin association was not previously
tested in Drosophila muscles, we co-immunoprecipitated
Dg::GFP and confirmed the Dg-Laminin association by
western blotting assay. These data show that the muscle-
expressed Dg forms a complex with laminin, as detected
with anti-LanB2 antibodies (Fig. 2b).
To further evaluate the Dg-LamininA association at
the cellular level, we performed immunohistochemical
co-staining of these two proteins in muscle tissue. Dg
protein has been previously shown to be expressed in
multiple types of Drosophila muscles and mainly lo-
calized to the muscle sarcolemma [13, 18, 62]. We
examined Dg-LamininA co-localization in the
skeletal-like body wall muscles of Drosophila wander-
ing larvae (Fig. 2c) and smooth-like visceral muscles
from adult reproductive (Fig. 2d) and digestive
(Fig. 2e) systems. We detected two Laminin chains,
LanA and LanB1, by expressing GFP-tagged versions
of these proteins, while LanB2 was detected with anti-
bodies. We observed that Dg and LamininA subunits
co-localize at the sarcolemma of the larval body wall,
oviduct, rectal ampulla, and hindgut muscles (Fig. 2c–
e), as well as at the larval neuromuscular junctions
(NMJs) (Fig. 2c, red arrows) and at the sites of
muscle attachments to the hindgut epithelium (Fig. 2e,
blue arrows). These results suggest that similarly to
mammalian Dg, Drosophila Dg binds LamininA in
muscle cells.
In addition, we tested several other components of the
muscle cytoskeleton for their association with Dg (Add-
itional file 2: Figure S1). We used lines expressing GFP-
tagged proteins [37] to visualize muscle expression pat-
terns of Hts and WupA cytoskeletal components. Hts/
Add (Hu li tai shao/Adducin) is an adducin homolog as-
sociated with the plasma membrane cytoskeleton that
has an essential function in adult somatic muscle devel-
opment [63]. Hts/Add is also deregulated at the NMJs in
amyotrophic lateral sclerosis (ALS) patients and ALS-
animal disease models [64]. Hts/Add is expressed in
both muscles and neurons and is enriched at the pre-
and post-synapse at the NMJs, where it controls synapse
elaboration and elimination [65]. Hts/Add is associated
with Na+/K+ ATPase, the ATP subunit , which was
also co-immunoprecipitated with Dg in this study
(Fig. 1e, Additional file 2: Table S1) and Coracle (Cora),
which has been previously shown to be deregulated at
the NMJs of Dg mutants [20]. At Drosophila NMJs, Dg
is expressed at the post-synapse, and its absence influ-
ences the localization of proteins involved in neurotrans-
mission, which abolishes NMJ functions [17, 20]. Now
we identified that Dg and Hts/Add are associated in the
Drosophila muscle tissue by testing Dg and Hts/Add
protein co-localization patterns. Importantly, we con-
firmed this association at the cellular level in different
muscle types (Additional file 2: Figure S1B, D, E). We
observed that in all muscle types, Hts/Add is present in
puncta at the sarcolemma where it co-localizes with Dg
(Additional file 2: Figure S1B, D, E). Moreover, in the
larval body wall muscles, strong enrichment of both pro-
teins was observed at the NMJs (Additional file 2: Figure
S1B). In addition, by western blotting assay, we con-
firmed that Hts/Add protein forms a complex with Dg
in adult muscles (Additional file 2: Figure S1C).
Next, we addressed Dg’s association with muscle thin
filament protein, Wings up A (WupA), which is the
component of the troponin complex involved in Ca2+-
dependent regulation of muscle contraction. WupA also
has been shown to be involved in the regulation of heart,
skeletal, and flight muscle development [66, 67]. Now,
our expression data show that in the muscles, Dg co-
localizes with the troponin complex component (Add-
itional file 2: Figure S1), suggesting that Dg could be in-
volved in the regulation of muscle contraction. In
support of this, we also have found several additional
proteins involved in myosin motor-based movement
along actin filaments to be associated with Dg, such as
tropomodulin, two troponin C isoforms, myosin light
chain C, myosin alkali light chain, actin 42A, crinkled,
gelsonin, and spaghetti squash (Fig. 1e, Additional file 2:
Table S1).
In summary, by analyzing Dg protein co-localization
and co-immunoprecipitation, we validated that proteins
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identified by mass spectrometry, such as LanA, LanB1,
LanB2, Hts/Add, and WupA, indeed associate with Dg
in muscle tissue. It implies that the candidates identified
in our screen can be used as a basis for further investiga-
tion of Dg interacting partners, manipulation of which
could combat the progression of muscle dystrophies and
cachexia.
Dg and the Hippo kinase signaling pathway interact to
sustain muscle integrity
Interestingly, together with Dg, we co-purified Kbr and
Yki (Fig. 1e, Additional file 2: Table S1), which are the
two members of the key evolutionarily conserved
mechanotransducing Hippo signaling pathway [27, 68].
Since mechanical signals regulate many aspects of
muscle cell behavior, including growth, differentiation,
and motility, we wanted to analyze in greater detail
whether Dg acts in concert with Hippo signaling to
regulate muscle growth and maintenance. The Hippo
signaling cascade was first discovered and characterized
in Drosophila (reviewed in [69, 70]). To transduce sig-
nals, Kbr together with Merlin (mammalian neuro-
fibromatosis type II, NF2) recruits the scaffolding
protein Salvador (mammalian WW45), which forms a
complex with the Hippo kinase (Hpo) or its mammalian
homolog Mst to phosphorylate and activate the DBF
family kinase Warts (mammalian Lats, Fig. 3a). Activated
Warts in association with the adaptor protein Mats
(mammalian Mob) phosphorylates and inhibits nuclear
translocation of another Dg-interacting protein found in
this study, the non-DNA-binding cofactor Yki (mamma-
lian Yap or Taz, Fig. 3a). Yki protein is a downstream ef-
fector of the Hippo signaling cascade directly involved in
the activation of gene expression, while Kbr and Hpo are
upstream components involved in the cascade activation
resulting in Yki’s phosphorylation and cytoplasmic re-
tention, thus downregulation of Yki activity. Therefore,
Kbr-mediated pathway activation results in the inactiva-
tion of the transcriptional regulator Yki (Fig. 3a). Intri-
guingly, our data show that Dg can associate and form
complex with both Kbr and Yki, which have opposite
roles in the Hippo signaling cascade. Since the role of
Dg in this signaling pathway is not fully understood, we
further tested these interactions. Particularly, we ad-
dressed whether Dg and the Hippo kinase signaling
pathway are physically and functionally interconnected
and whether this association is biologically relevant for
muscle function and MD development using several
approaches.
Firstly, we evaluated Yki and Kbr expression in Dros-
ophila muscles (Additional file 2: Figure S2 and S3). We
detected Kbr expression by antibody staining in the
cytoplasmic puncta in different types of muscles (Add-
itional file 2: Figure S2A-C). For Yki detection, we ana-
lyzed the muscles of animals expressing GFP-tagged Yki
[37] and identified patterns similar to Kbr expression
(Additional file 2: Figure S3A-C). Moreover, both Kbr
and Yki co-localized with Dg at the puncta adjacent to
the muscle cell membrane (Additional file 2: Figure S2D
and S3D).
Secondly, we tested the biochemical association be-
tween Dg and Hippo signaling. Intriguingly, the associ-
ation of Dg and Dys in human and Drosophila relies on
WW domain-mediated protein interactions [13, 19, 71,
72]. In fact, the cytoplasmic region of Dg protein con-
tains two functional WW domain-binding PPxY motifs,
whose function can be regulated by tyrosine phosphoryl-
ation, which affects Dg-Dys interaction [72]. Similar to
Dys, Drosophila Kbr protein, identified by mass spec-
trometry to be associated with Dg, also contains two
WW domains (Additional file 2: Figure S4). Further-
more, it has been shown that the core components of
the Drosophila Hippo pathway, like in mammals, associ-
ate with each other via PPxY motif-WW domain inter-
actions [73]. We specifically focused on Dg interaction
with a critical component of this mechanotransducing
pathway, Kbr. While binding of Dg peptide to Kbr WW
tandem has been recently reported [74], Dg-Kbr inter-
action has not been demonstrated in any animal in vivo.
We expressed a GFP-tagged Dg protein using Mhc-Gal4
and immunoprecipitated complexes from whole fly ex-
tracts using anti-GFP beads. Immunoblotting with anti-
(See figure on previous page.)
Fig. 2 Dg associates with three laminin subunits in the muscles. a Schematic drawing of the LamininA heterotrimer containing α3.5 (encoded by
LamininA, LanA gene), β (encoded by LamininB1, LanB1), and γ (encoded by LamininB2, LanB2) chains. b Co-IP verifies Dg and LanB2 interaction
in the muscles. c–e Dg and laminin protein co-localization in the larval body wall (c), adult oviduct (d), and adult rectal ampulla and hindgut (e)
muscles. c–e (Left panels) schematics of the larval body wall muscles, adult ovarian muscles, and adult digestive system muscles (drawings
adapted from [18]). The striated larval body wall muscles are the functional equivalents of vertebrate skeletal muscles. Although striated, the
visceral muscles surrounding the gut and gonads are functionally analogous to vertebrate smooth muscles. c (Right panel) confocal images of
the larval body wall muscles (VL1-4) presented as maximum intensity projections from multiple z-sections. Yellow arrows show Dg and laminin
subunit co-localization at the sarcolemma and red arrows point to the Dg- and Lan-enriched NMJs. d (Right panel) images of single z-sections of
the oviduct muscles. Yellow arrows show Dg and laminin co-localization at the muscle cell membrane. e (Right panel) images of single z-sections
of the rectal ampulla muscles and cross-sections of hindgut muscle cells (for orientation, see the scheme). Yellow arrows show Dg and Lan co-
localization at the muscle cell membrane, and blue arrows point to the muscle attachment sites. Dg—red; LanA, LanB1, and LanB2—green;
DAPI—blue. Expression patterns for Dg, laminins, and DAPI are also shown in separate channels
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GFP antibodies allows recognition of the Dg::GFP fusion
protein only in extracts from Mhc>Dg::GFP. Importantly,
immunoblotting with an anti-Kbr antibody suggests that
Kbr and Dg can associate and form complex (Add-
itional file 2: Figure S2E). To assess the possibility of
non-specific interactions between Kbr and GFP, we also
overexpressed membrane-tagged GFP using the same
driver (Mhc>CD8::GFP). Immunoblotting with anti-Kbr
confirms that the interaction with Kbr is specific for Dg
(Additional file 2: Figure S2F). We propose that this
interaction may occur via PPxY motif-WW domain in-
teractions; however, this hypothesis needs to be further
tested by mutagenesis of the putatively interacting do-
mains. In addition, Drosophila Yki also contains WW
domains (Additional file 2: Figure S4), and Dg-Yap bind-
ing through PPxY-WW interaction has been recently
demonstrated in mice [36]. However, a recent study
showed that in human cells, Dg can bind the WW tan-
dem domain of Kbr, but not Yki/Yap [74]. Therefore,
further studies are required to further dissect the bio-
chemistry of Dg interaction with these Hippo signaling
factors.
Thirdly, we wanted to test whether Dg functionally in-
teracts with the Hippo pathway components and
whether this interaction is important for the mainten-
ance of adult muscle tissue. A great tool to test for a
functional interaction between genes is the genetic inter-
action approach. It evaluates the effect of pairwise gene
deletion or gene expression inhibition on the outcome
of a particular phenotype. On one hand, this analysis al-
lows to identify the functional association between
genes, even if their physical interaction is weak or transi-
ent. On the other hand, genetic interaction screens can-
not discriminate between direct and indirect
interactions; however, they provide evidence for involve-
ment in the same pathway or process and give additional
information about gene function and pathways. To test
for the functional interaction of Yki and Kbr with Dg,
we generated trans-heterozygous mutants that had
reduced by one copy Dg and Kbr or Yki and analyzed
the integrity of their muscles.
In particular, we analyzed the morphology of indirect
flight muscles (IFMs) in young (7-day-old) and aged (28-
day-old) animals and quantified the muscle degeneration
phenotype (Fig. 3b, Additional file 2: Table S4). IFMs are
fast-twitching muscles with high mitochondrial content
necessary for long-lasting oxidative metabolism. In
addition to calcium stimulation, these asynchronous
muscles require stretch activation to induce their con-
tractions [75]. In young animals, no significant increase
in muscle degeneration was observed in animals bearing
only one copy of Dg, yki or kbr (DgO55/+, ykiB5/+, or
kbrdel/+, respectively) or in flies trans-heterozygous for
Dg and Hippo pathway components (DgO55/ykiB5 or
DgO55/+; kbrdel/+), when compared to controls (w1118/+,
7 days old, Fig. 3c–f). Aged control flies had a substan-
tial muscle degeneration phenotype (w1118/+, 28 days
old); moreover, heterozygous DgO55/+, ykiB5/+, or kbrdel/
+ animals displayed significantly increased muscle de-
generation (28 days old, Fig. 3b), suggesting that the re-
duction of the Hippo signaling components by one copy,
similarly to reduction of Dg, leads to age-dependent
muscle degeneration. Interestingly, this phenotype was
characterized by either moderate or strong changes in
the muscle morphology resulting in muscle fiber loss
(blue and red arrows and bars, respectively, Fig. 3c–f).
Importantly, in the muscle tissue, the trans-
heterozygous combination of Dg and kbr (DgO55/+;
kbrdel/+) resulted in a significant increase of both
strong and moderate muscle degeneration phenotypes,
when compared to respective controls (28 days old,
Fig. 3b). At the same time, the reduction of yki ex-
pression by one copy in the Dg heterozygous back-
ground partially rescued the age-dependent muscle
degeneration phenotype. These data show that in
adult muscles, Dg genetically interacts and cooperates
with Kbr to promote the Hippo signaling cascade re-
quired to maintain muscle tissue integrity during
(See figure on previous page.)
Fig. 3 Hippo signaling pathway components modify the Dg-linked muscle degeneration phenotype. a Scheme of the Hippo kinase signal
transduction pathway, major components of which are evolutionarily conserved from flies to humans. Kbr is a Hippo signaling activator. Wts/Lats
phosphorylates transcriptional co-activator Yki, which prevents its relocation from the cytosol to the nucleus. Two components of the pathway
Kbr (orange) and Yki (yellow) were identified by the mass spectrometry analysis to be associated with the Dg protein. b Bar graph represents the
quantification of the moderate and strong IFM degeneration phenotypes (blue and red bars, respectively) in young (7-day-old) and aged (28-day-
old) animals (Additional file 2: Table S5). Aging per se causes significant muscle degeneration (see 28-day-old control w1118/+, and black stars
indicate statistical significance. Reduction of Dg, kbr, or yki by one copy additionally increases moderate—and in particular, strong—muscle
degeneration in old animals (see 28-day-old DgO55/+, ykiB5/+, kbrdel/+ and blue stars for statistics). The introduction of the Hippo pathway
mutations into a Dg heterozygous background significantly modifies the age-dependent muscle degeneration phenotype (Additional file 2: Table
S5). In particular, the reduction of yki by one copy suppresses (see DgO55/ykiB5 and green stars for statistics), while reduction of Kbr by one copy
enhances (see DgO55/+, kbrdel/+, and pink stars for statistics) the frequency of muscle degeneration observed in Dg heterozygous mutants. c–f
Hematoxylin and eosin (H&E)-stained transverse sections of indirect flight muscles (IFMs) of 28-day-old control (w1118/+), Dg heterozygous (DgO55/
+), Dg and yki trans-heterozygous (DgO55/ykiB5), and Dg and kbr trans-heterozygous (DgO55/+, kbrdel/+) animals. Blue and red arrows point to
moderate and strong muscle degeneration, respectively
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aging and suggest that Dg acts to repress the nuclear
function of Yki.
In summary, our results demonstrate that in the mus-
cles, the transmembrane protein Dg physically and func-
tionally interacts with the Hippo signaling pathway, in
particular, the WW domain proteins, Yki and Kbr, and
this interaction is required to sustain muscle integrity
during aging.
The Hippo kinase signaling pathway cell autonomously
regulates adult muscle integrity
Currently, Hippo signaling has not been shown to play a
role in adult muscle maintenance in Drosophila. Since
we identified that during aging, Dg and the Hippo sig-
naling components interact to maintain muscle integrity,
we wanted to analyze the Hippo pathway requirement in
adult muscles. Similar to Dg, the components of the
Hippo pathway are expressed in various tissues; there-
fore, we wanted to test whether Hippo signaling is in-
volved in the cell-autonomous regulation of muscle
integrity. In particular, we analyzed the consequences of
the muscle-specific down- or upregulation of Hippo
pathway components using different Gal4 drivers. Im-
portantly, the downregulation of Yki with Mef2-Gal4
driver resulted in the complete loss of indirect flight
muscles, IFMs (Additional file 2: Figure S5), while its
downregulation with Mhc-Gal4 resulted in the appear-
ance of flies with relatively normally developed muscles.
Mef2 (myocyte enhancer factor 2) is a transcription fac-
tor required for the activation of a large number of
muscle protein genes essential for muscle development,
while Mhc (myosin heavy chain) is the motor protein
providing the force for muscle contraction and is
expressed in already differentiated muscles. Based on
these observations, we conclude that Yki is essential for
muscle development and that the Mhc-Gal4 driver is
more suitable to assay the role of Yki and other Hippo
pathway mutants in muscle maintenance during
adulthood.
As negative and positive controls, we used heterozy-
gous Mhc-Gal4/+ flies and flies that had Dg downregu-
lated by RNAi in the muscles using the same driver
(Fig. 4a). The frequencies of degenerated muscles were
similar in young control and mutant flies that had Dg
downregulated either in the whole organism (DgO55/+)
or in the muscle tissue specifically (Mhc-Gal4>DgRNAi).
However, aged animals with a muscle-specific reduction
of Dg showed lower percentages of degenerated muscles
than Dg heterozygotes (compare Fig. 3b and 4b, Add-
itional file 2: Table S4). Since it is known that Dg has
additional important functions, for example, in the ner-
vous system, these data suggest that during aging, Dg ex-
pression in non-muscle tissues also contributes to
muscle maintenance.
Notably, when we analyzed aged animals with reduced
Dg levels in the muscles, we observed that the appear-
ance of muscle tissue was altered, which manifested as
the apparently increased space between muscles (Fig. 4a,
black arrows). In particular, muscles of aged flies sepa-
rated from the epimysium, a fibrous tissue enveloping
each muscle (Fig. 4a, black arrows). Such morphological
changes do not necessarily cause myofiber loss or degen-
eration, but rather appear as a result of the decreased
mass and size of myofibers and muscles. This phenotype,
observed in Drosophila, resembles the clinically de-
scribed muscle atrophy in humans, which is the reduc-
tion in muscle mass leading to muscle weakness.
Importantly, similar defects were observed in young and
aged Hippo signaling mutants (Fig. 4c, d). Notably,
muscle atrophy is often observed in various diseases, in-
cluding cancer, AIDS, congestive heart failure, chronic
obstructive pulmonary disease, and renal failure. More-
over, starvation and age-related sarcopenia ultimately
lead to muscle atrophy. Muscle atrophy can also develop
to “cachexia” or wasting syndrome with poor prognosis
and recently; Hippo signaling has been associated with
cachexia in a mouse cancer model [76]. Therefore, we
wanted to analyze the muscle atrophy phenotype caused
by Dg and Hippo signaling defects in greater detail.
Deregulation of Hippo signaling affects muscle size and
results in age-dependent muscle atrophy
To evaluate the severity of muscle atrophy caused by
muscle-specific Dg and Hippo signaling pathway deregu-
lation, we analyzed the muscle size in control and mu-
tant young and old animals. In particular, we focused on
the indirect flight muscles (IFMs), as they represent one
of the largest groups of adult muscles in Drosophila
(Fig. 5a). IFMs do not directly drive wing movements
but are involved in the deformation of the thorax to
which the wing is attached, which indirectly leads to
wing movements. These striated muscles closely resem-
ble vertebrate striated muscles, as their organization,
contraction, and relaxation are almost identical. These
muscles are also extremely energy-dependent, since they
are required for the exceptionally high wing beat fre-
quency observed in insects [77]. These muscles contain
a lot of mitochondria for long-lasting oxidative metabol-
ism and little sarcoplasmic reticulum. There are 2 sets of
IFMs—dorsal-ventral (DVM) and dorsal-longitudinal
(DLM) muscles—which occupy a large part of the thor-
acic region and work antagonistically (Fig. 5a). Here, we
measured the cross-sectional area of the DLMs. This
group consists of 12 (6 on each side) muscles, elongated
along the anterior-posterior axis and relatively similar in
their cross-sectional appearance. This regularity is useful
for quantitative and qualitative assessment of the muscle
atrophy phenotype (Fig. 5a).
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We found that in controls, the size of each DLM de-
pends on its position, in that the most-dorsal and most-
ventral muscles (pairs 1, 2, and 6) are smaller (~ 2200–
2500 μm2), while the cross-sectional area of the longer
muscles (pairs 3, 4, and 5) is larger (~ 3000 μm2, Fig. 5b,
Additional file 2: Figure S6 and Table S6). Importantly,
upon aging, the size of all muscles, regardless of their
previous size or position, was significantly reduced in a
similar manner (compare green and red lines for young
and aged flies in Fig. 5b, Additional file 2: Figure S6). On
average, in aged controls, the cross-sectional area of each
muscle was ~ 10% smaller than in young flies (Fig. 5c,
Additional file 2: Figure S6 and Table S6). This tendency
for age-dependent muscle atrophy was observed for all
genotypes. Importantly, the correlation analysis between
7- and 28-day-old muscles shows correlations exclusively
> 92% (Fig. 5b, ρ = correlation index). Such significant
positive correlation demonstrates that essentially every
muscle has similar rates of atrophy upon aging.
In addition, young flies that had Dg and Yki levels re-
duced specifically in the muscles had dramatically
smaller muscles (~ 20% and ~ 40% reduction of the
muscle area, respectively), suggesting that Dg and Yki
control proper muscle size already in young animals
(Fig. 5c). Since all aged animals regardless of the geno-
type showed some degree of muscle atrophy upon aging,
next, we measured the amount of muscle loss by com-
paring the average muscle area in aged vs. young animals
of the same genotype (Fig. 5d). Since every muscle pro-
portionally atrophied, we also assayed the absolute
amount of muscle loss by subtracting the average muscle
area of aged from the average muscle area of young flies
(Fig. 5e). Interestingly, for mutants with Dg downregula-
tion, the rate and the total amount of atrophy were not
significantly different from controls, implying that while
muscle-specific reduction of Dg levels during adulthood
leads to age-dependent muscle degeneration (Fig. 4a, b),
it does not accelerate age-dependent muscle atrophy
(Fig. 5d, e; Additional file 2: Tables S5-S6). A similar
tendency was observed in muscles with Yki upregulation,
both the rate and the total amount of muscle loss were
similar to controls. At the same time, Yki downregula-
tion had a dramatic effect on age-dependent
maintenance of muscle size. YkiRNAi muscles were
already significantly smaller in young animals; moreover,
their size was additionally decreased upon aging (~ 20%
and ~ 300 μm2, Fig. 5d, e; Additional file 2: Table S6)s.
Similar results were obtained in mutants that had Kbr
up- or downregulated. However, in comparison with Yki
downregulation, the average relative muscle atrophy was
lower, while the absolute amounts of muscle area loss
were higher (~ 15% and ~ 400μm2, Fig. 5d, e; Add-
itional file 2: Table S6).
Together, these data show that in Drosophila, the
Hippo signaling pathway is involved in the control of
age-dependent maintenance of muscle size. Importantly,
Yki downregulation had a more dramatic effect on
muscle growth already in young animals, suggesting that
Hippo signaling activation has a negative effect on
muscle growth. These data are consistent with the previ-
ous report that shows that in mammals, YAP/Yki posi-
tively regulates basal skeletal muscle mass and protein
synthesis [32]. Also, we observed that the muscle-
specific perturbation in Kbr expression (Mhc>kbrRNAi
and Mhc>kbr) significantly increases muscle atrophy
upon aging, when compared to respective young mu-
tants (Fig. 5c–e, Additional file 2: Tables S5-S6). Since
age-dependent muscle atrophy was observed upon both
downregulation and overexpression of Kbr, we conclude
that during adulthood, the proper balance in Hippo sig-
naling activity is important for muscle size maintenance.
Dg-Kbr association is conserved in mammals
In accordance with the studies in mammalian heart
muscles [36, 78], our current work also demonstrates
that in Drosophila muscles, Dg associates with Yki, sug-
gesting that the previously proposed Dg function in Yki/
Yap sequestration could be conserved. In addition, our
data show that in Drosophila, Dg interacts with another
Hippo pathway factor, Kbr, and recent studies demon-
strated the possibility of Kbr-Dg interaction in human
cells [74]. Therefore, we tested if Dg interacts with Kbr
in mammalian muscles. Firstly, we immunoprecipitated
beta-Dg (DAG1) from extracts from mouse tibialis an-
terior muscles, which consist of a mixture of oxidative
and glycolytic muscle fibers. Then, we analyzed the
(See figure on previous page.)
Fig. 4 Hippo kinase signaling pathway controls muscle size. a Images of transverse sections of IFMs from young and aged (7- and 28-day-old)
controls (Mhc-Gal4/+) and mutant flies with the muscle-specific Dg downregulation (Mhc>DgRNAi). Note the appearance of moderate muscle
deterioration upon Dg downregulation in young flies (blue arrows) and strong muscle deterioration in aged flies (black arrows). b The bar graph
shows the frequencies of moderate (blue bars) and strong (red bars) muscle degeneration in controls and in flies with Dg downregulation in the
muscles. c Images of transverse sections of IFMs of aged mutant flies with kbr and yki up- or downregulation in the muscles. Note that in all
genotypes, no obvious muscle degeneration is observed; however, the muscles appeared to be smaller in size. ***p≤ 0.001; **p≤ 0.01; *p ≤ 0.05.
d Enlarged view of IFMs. Downregulation of Dg (Mhc-Gal4>DgRNAi) and up- and downregulation of yki (Mhc-Gal4 >ykiRNAi, Mhc-Gal4>yki) or kbr
(Mhc-Gal4>kbrRNAi, Mhc-Gal4>kbr) result in the appearance of smaller muscles, when compared to control (Mhc-Gal4/+). The yellow dashed line
outlines an individual muscle (muscle 5). Black arrows point to muscle atrophy, which is detected by smaller muscle cells clearly separated from
the neighboring cells
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Fig. 5 (See legend on next page.)
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protein precipitates by SDS-PAGE and immunoblotting
using Kbr and beta-Dg antibodies. The co-
immunoprecipitation assay shows that the two proteins
also interact in mammalian muscles (Fig. 6a). Secondly,
we tested Kbr-Dg co-localization using an immunohisto-
chemical approach. For this, we co-stained mouse myo-
tubes differentiated from C2C12 myocytes with anti-
DAG1 and anti-Kbr antibodies (Fig. 6b). Analyses of
staining patterns confirm the co-localization of both
proteins at the sarcolemma of differentiated muscle cells
in vitro. Thirdly, to confirm Dg-Kbr co-localization
in vivo, we stained the cryo-sections of mouse leg mus-
cles (Fig. 6c). We found that these two proteins co-
localize at the muscle sarcolemma, which is similar to
our findings in Drosophila. Together, these data for the
first time show that the ECM receptor Dg interacts with
the Hippo signaling component, Kbr in vivo; moreover,
this interaction is evolutionarily conserved. Since in
addition to Kbr, Dg also interacts with another Hippo
component, Yki that plays an opposing to Kbr role in
the transduction of Hippo signaling cascade, our data
suggest that apart from being a physical link between
the ECM and the cell cytoskeleton, muscle Dg functions
as platform for Hippo cascade components to modulate
the strength of this pathway (Fig. 7). Interestingly, Dg
supports Hippo signaling and negatively regulates func-
tional Yki, which can occur via two possibly synergistic
mechanisms: (1) Dg binds Kbr at the sarcolemma, which
stabilizes Kbr and its association with the associated pro-
teins of the Hippo signaling cascade, which facilitates
phosphorylation and degradation of cytoplasmic Yki; (2)
Dg binds Yki at the sarcolemma, which sequesters it
from the cytoplasmic pool and reduces the amount of
Yki available for nuclear function. In the other model,
Dg can bind the phosphorylated Yki and protect it from
degradation. At least our genetic interaction data in
IFMs propose that Dg and Kbr act together to enhance
Hippo signaling, supporting the first model. However,
more experiments are needed to dissect the exact mech-
anism of Dg-Yki and Dg-Kbr interaction.
Discussion
The ECM proteins
The majority of diagnosed secondary dystroglycanopa-
thies are associated with abnormal glycosylation of Dg,
which affects its association with the ECM molecules.
One of the most important Dg glycosylases is LARGE
[59, 79–86]. Intriguingly, while the Drosophila genome
lacks LARGE homologs, it contains genes encoding O-
mannosyltransferases, which are involved in the transfer
of D-mannose from dolichyl-phosphate-D-mannose onto
serine or threonine residues of target proteins, including
Dg. These O-mannosyltransferases, Rt/POMT1 and tw/
POMT2, function in association with each other to
maintain normal muscle development and the sensory
feedback controlling muscle contractions [87]. POMT
genes are evolutionarily conserved in metazoans. Genetic
defects in either protein O-mannosyltransferase, POMT1
or POMT2, underlie severe muscular dystrophies in
humans. Specifically, a form of dystroglycanopathy, a
limb-girdle muscular dystrophy (type C2; MDDGC2), is
caused by homozygous or compound heterozygous mu-
tation in the POMT2 gene. In addition, Walker-
Warburg syndrome and muscle-eye-brain disease are
also caused by genetic defects affecting these genes [88].
It is also noteworthy that the pair of threonines in α-
Dg that are modified by LARGE is not conserved in
multiple phyla [89]. In general, in some vertebrates, it
was observed a lower degree of sequence conservation at
the level of the N-terminal region of Dg, which normally
consists of immunoglobulin-like domain G1 (IG1), S6
(similar to the Ribosomal protein S6, a constituent of
(See figure on previous page.)
Fig. 5 The Hippo pathway and Dg regulate muscle size and atrophy. a Schematic drawing of a fly from lateral and cross-section views indicates
the position of the analyzed IFMs. The numbers for the pairs of dorsolateral muscles (DLM) are indicated in the cross-section view. b The bar
graphs represent the average sizes of the muscles in different DLM pairs in young flies (7 days old) in controls or upon downregulation of Dg
(Mhc-Gal4>DgRNAi) and up- and downregulation of yki (Mhc-Gal4>ykiRNAi, Mhc-Gal4>yki) and kbr (Mhc-Gal4>kbrRNAi, Mhc-Gal4>kbr). The green line
outlines the averaged sizes of the young control muscles (shown in all genotypes for comparison), while the blue line indicates the aged control
muscles. The yellow line corresponds to the averages of muscle size in mutant young animals, and the red line shows the average for aged
animals of the corresponding genotype. Note that in all genotypes, on average, all muscles are similarly reduced in size. The correlation between
the cross-sectional area of each muscle in young vs. old flies of the same genotype is shown at the top left corner of each graph (ρ = correlation
index). Correlation is exclusively > 92%, signifying a nearly perfect positive correlation between 7 and 28 days (essentially, every muscle atrophies
between day 7 and day 28). c The bar graph shows the average of relative muscle size in young and aged control and mutant flies. Aging causes
a significant reduction in muscle size when compared to 7-day-old controls (black asterisks). Note that muscle size significantly decreases with
age in all genotypes (red asterisks, compared to 7-day-old animals of the same genotype) (see also Additional file 2: Table S5). d The bar graph
shows the amount of age-dependent muscle atrophy, when compared to 7-day-old animals of the same genotype (see also Additional file 2:
Table S6). Note that muscle atrophy is differentially increased with age upon muscle-specific yki downregulation and kbr up- and downregulation.
e The bar graph shows the absolute amount of age-dependent muscle atrophy (μm2). To measure this value, the averaged area of an individual
muscle in old flies was subtracted from the corresponding value in young flies. Note that animals with kbr up- and downregulation have the
highest amount of muscle size loss (see also Additional file 2: Table S6). ***p≤ 0.001; **p≤ 0.01; *p≤ 0.05 (black, compared to 7-day-old control;
red, compared to 7-day-old animals of the same genotype). Two-tailed Student’s t test was applied for statistical analysis
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ribosomes), and the heavily glycosylated mucin-like do-
mains, which is of particular interest due to the import-
ance of Dg’s binding to the ECM proteins, especially
laminins, and also with regard to the general role of mu-
cins that can sterically affect integrin clustering [90, 91].
For example, Drosophila Dg has a mucin-like domain
that can play a role in Dg’s interaction with laminins;
while Caenorhabditis elegans Dg completely lacks a
mucin domain, and it is not clear whether or how it in-
teracts with laminin. It was suggested, however, that the
IG1 domain can show some weak laminin-binding activ-
ity and could provide an alternative mode of Dg-
Laminin interaction or that binding to other ECM li-
gands such as perlecan has evolved to predominate over
laminin binding [89]. Moreover, it has been previously
found that levels of laminins as well as integrin depend
on Dg expression levels [21]. Moreover, Dg is involved
in the regulation of the ECM constitution and is capable
of readjusting the levels of ECM components at the level
of transcription [21]. Overexpression of a form of Dg
containing only the extracellular, but lacking the intra-
cellular, domains caused abnormal integrin and laminin
distribution, demonstrating that the presence of the
ECM-interacting domain of Dg is sufficient to modulate
the expression of proteins.
In Drosophila, similar to vertebrates, Dg is also heavily
glycosylated [50]. While Dg glycosylation has been inten-
sively studied, some steps are still not very well under-
stood. Importantly, we also found in our screen that
Drosophila Dg, similar to mammalian Dg [92, 93], can
interact with several lectin proteins, in particular with C-
type lectins CG6055, CG4115, and Clect27. In general,
Dg’s interactions with the ECM proteins, such as lectins
and laminins, depend on elaborate carbohydrate modifi-
cations of Dg, which normally occur in the ER and Golgi
[59, 88, 93]. We have identified several constituents of
these subcellular organelles (Fig. 1d, Additional file 2:
Table S1), which can be proposed as new candidates that
could serve to manage proper Dg glycosylation. For ex-
ample, among the detected proteins were a small
Fig. 6 Similar to Drosophila, dystroglycan (DAG1) and Kibra interact in mammalian muscles. a Co-immunoprecipitation of beta-Dg (DAG1) and
Kbr from mouse muscle extracts (tibialis anterior muscles, consisting of a mixture of oxidative and glycolytic muscle fibers) shows that the two
proteins can form a complex in mammalian muscles. b Co-staining of mouse myotubes differentiated from C2C12 myocytes with anti-DAG1 (red)
and anti-Kbr (green) antibodies. Arrowheads show the co-localization of both proteins at the sarcolemma of differentiated muscle cells in vitro. c
Co-staining of the cryo-sections of mouse leg muscles (quadriceps femoris, a mixed slow- and fast-twitch oxido-glycolytic muscle) with anti-DAG1
and anti-Kbr antibodies demonstrate the co-localization of the proteins at the muscle sarcolemma in vivo, which is similar to our findings in
Drosophila (see Additional file 2: Figure S2)
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GTPase Sar1 that is recruited to the endoplasmic
reticulum and initiates the recruitment of the COPII
subunit complex Sec23/Sec24 mediating anterograde
protein transport from the ER to Golgi and two small
GTPases that contribute to vesicle trafficking regulation,
Rab7 and Rab18 (Additional file 2: Table S1). We did
not expect to see Dg interaction with any modifying pro-
teins per se because normally, most of the enzymatic in-
teractions are transient, “kiss-and-run’ interactions, and
thus unlikely to be detected by mass spectrometry. In
general, identification of substrates of glycosylating en-
zymes is hampered by the weak affinity of substrates for
the enzyme and because the complex between the sub-
strate and the glycosylating enzyme is transient. How-
ever, we did identify an uncharacterized protein,
encoded by CG33303, which could be involved in N-
linked Dg glycosylation. CG33303 is a homolog of hu-
man Riboporin 1, a subunit of oligosaccharyltransferase
in the ER [94], and therefore, in the future, it would be
interesting to study this protein in greater detail.
Membrane-associated proteins
We detected seven membrane-associated factors that
mainly mediate transmembrane transport (Fig. 1d, e;
Additional file 2: Table S1): transmembrane ion channel
components (PMCA, ATPalpha, nrv1, and Vha100-2)
and a drug transporter (CG10226). It has been previ-
ously reported that besides providing structural integrity
to the sarcolemma, Dg is also involved in the regulation
of intracellular calcium ions (Ca2+), specifically handling
the import/export of Ca2+ in response to the level of
intracellular Ca2+ stored in the sarcoplasmic reticulum
[20, 95]. Previously we reported that blockage of calcium
channels rescues Dg-linked seizures in adult Drosophila
[20]. Now, we identified that Dg associates with PMCA,
a plasma membrane calcium ATPase (P-type ion pump)
that functions as a low-capacity, high-affinity Ca2+ extru-
sion apparatus required for maintaining resting Ca2+
levels in all cells. It has been previously reported that in
Drosophila larval NMJs, PMCA plays an important role
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Fig. 7 Dual roles of Dg as an ECM receptor for the dystrophin glycoprotein complex and a mechanotransducing receptor for Hippo signaling.
Drawing of the DGC and the Hippo pathway association in the muscle cell. The DGC is positioned at the sarcolemma. The extracellular part of the
transmembrane protein Dg binds the ECM protein LamininA, and Dg’s intracellular region interacts with the Hippo kinase signaling pathway
components, Kbr and Yki. Kbr is a positive regulator of the Hippo kinase signaling that through the cascade of phosphorylation reactions results in
phosphorylation of the transcriptional co-activator Yki. Phosphorylated Yki does not translocate to the nucleus to regulate gene expression but
remains in the cytoplasm, where it is subjected to degradation or alternatively, it can be bound to Dg. Dg promotes Hippo signaling via association
with Kbr and can interact with the Hippo transcriptional co-activator Yki. Hypothetically, Yki-Dg interaction can protect cytoplasmic phosphorylated Yki
from degradation and contribute to the Yki pool for quick response to mechanical stress or Dg can sequester non-phosphorylated Yki preventing it
from entering the nucleus for gene expression regulation. In adult Drosophila muscles, Hippo signaling is required to control muscle integrity and size,
during development and upon aging. Our data show that Dg genetically interacts with Kbr and Yki to maintain muscle integrity during aging. Our
results suggest that muscle Dg is a Hippo signaling receptor that transmits mechanical stress from the ECM to the cytosolic signaling regulating gene
expression. However, it is not clear whether in adult muscles Dg-Laminin interactions influence Hippo signaling, whether Dg-Kbr/Yki and Dg-Dys
complexes are related and if they rely on the interactions thought the same PPxY motifs on Dg’s C-terminus, whether Dg interacts with
phosphorylated or non-phosphorylated Yki, and which genes are regulated by the Dg-Hippo pathway in adult muscles
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synaptic Ca2+ influx [96]. Our new findings suggest that
Dg might associate with PMCA at the NMJ sites to
regulate cellular Ca2+ levels, which is consistent with Dg
protein elevation at the NMJ post-synapses [20]. In sup-
port of a role for Dg in the regulation of muscle cell cal-
cium homeostasis, several calcium channel subunits
(Cacna1c, Cacna1e, Cacnb3) were also co-purified with
Dg in mice [9].
Another ion channel proteins that we identified to be
putatively associated with Dg are - ATPα and Nrv1
(Nervana1), which are α- and β-subunits of the Na+, K+
ATPase ion pump important for maintaining cellular
membrane potential in the muscles [97]. Previous stud-
ies report that the activity of α3 Na+, K+ ATPase can be
modulated by the ECM protein Agrin in mouse cardiac
myocytes, influencing their contraction [98]. The N-
terminal region of Agrin binds laminin, while the C-
terminal end binds to several transmembrane ECM re-
ceptors, including Dg; however, whether Agrin-linked
regulation of Na+, K+ ion pump depends on Dg remains
unrevealed.
Among identified proteins, we also detected a drug
transporter of the ABC family. While drug transporters
of the SLC family are largely uptake transporters that
regulate the influx of small substances into the cell, the
ABC family transporters function as efflux transporters
(reviewed in [99]). Active efflux is a mechanism crucial
for moving compounds like neurotransmitters, toxic
substances, and antibiotics out of the cell. In fact, ABC
transporters are handling diverse substances, including
metabolites, antioxidants, signaling molecules, hor-
mones, nutrients, and neurotransmitters [99]. Deeper
studying of Dg interaction with these proteins may help
to explain the impaired metabolism and increased sensi-
tivity to metabolic stress observed in Drosophila Dg-
deficient mutants [18, 39, 100]. Moreover, even though
the molecular basis for Duchenne and Becker MDs has
been known for several decades, until now, the only
medications found to be effective in ameliorating the ef-
fects of these disorders are corticosteroids [101]. Recent
work also showed a positive effect of glucocorticoid ste-
roids and alendronate treatment on dystrophic pheno-
type in the LGMD mouse model [102]. A limited
number of medications improving MDs demand a vast
input into the research on new drug development and
in-depth examination of drug response mechanisms in
MD patients. Unusual drug reactions and complications
during anesthesia were previously described for a high
percentage of patients with MDs [103]. It was found that
a polymorphism in genes encoding the ABC efflux drug
transporters affect the handling of drugs in human can-
cers [104, 105]. Now, we identified the association of Dg
with the ABC family transporters. Further investigation
of the functional relevance for such interaction might be
crucial for improving drug usage in MD treatment. Re-
garding the identified membrane-associated Dg-
interacting proteins, the question of whether Dg regu-
lates their function or ensures proper clustering and
localization at the plasma membrane also remains open
for further studies.
Cytoskeletal proteins
It is well known that Dg is a linker between the ECM
and the actin cytoskeleton. Similar to vertebrates, in
Drosophila, the intracellular part of Dg binds the cyto-
solic protein Dys [13], which is connected to actin.
Other studies also showed that the cytoplasmic tail of β-
Dg interacts directly with F-actin [106]. We did not,
however, detect Dys to associate with Dg in our prote-
omic experiments, and this may be explained by several
factors. The mass spectrometric analysis of muscle pro-
teins has detection limitations—in particular, molecules
that are of relatively low abundancy or proteins with a
large molecular mass that exists in weak association with
a variety of other proteins [107, 108]. Indeed, these fea-
tures describe Dys protein. First, the low abundance of
Dg-Dys complexes is supported by the reported mea-
surements; in mouse and rabbit muscles, Dg and Dys
proteins are expressed with the ratio 41:1 and 43:1, re-
spectively [9]. In Drosophila muscles, Dg levels detected
by antibody staining are also noticeably higher in com-
parison with Dys levels [18]. Second, in the human gen-
ome, dystrophin (DMD) is the largest gene, spanning a
genomic range above 2Mb and encoding for a protein
of 3685 amino acid residues [109]. Similarly, Drosophila
Dys protein size can reach 3598 amino acids in length,
depending on the isoform (annotated in FlyBase). More-
over, it has been shown that the Dg-Dys interaction is
weak and occurs at the micromolar range [13], which
adds a further challenge for protein complex detections
using global proteomics analysis. Another possible ex-
planation is that a direct interaction of Dg with Kbr or
other Dg interactors could stably displace the interaction
with Dys in the adult Drosophila muscles. Neverthe-
less, by our proteomics approach, we could detect
several cytoskeletal proteins to interact with Dg (Add-
itional file 2: Table S1), demonstrating the abundance
or strong affinity of their interaction with Dg in mus-
cles. In particular, we detected 16 components of the
actomyosin cytoskeleton to be associated with Dg,
among them myosins, myosin- and actin-binding pro-
teins, and Ca2+-binding troponins (Fig. 1e, Add-
itional file 2: Table S1). Therefore, it would be
important to study further the molecular mechanisms
of Dg’s association with these cytoskeletal proteins, as
well as other cytosolic proteins regulating the cell
cytoskeleton (Fig. 1e).
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Cytoplasmic proteins
Among the cytoplasmic proteins associated with Dg, we
found factors that regulate protein biosynthesis, traffick-
ing, and degradation, as well as components that control
cellular metabolic processes and mitochondrial func-
tions. The identification of ER-associated components,
cytoplasmic vesicle-associated proteins, and a number of
aminopeptidases that regulate protein degradation can
help to follow Dg’s cellular lifecycle from biosynthesis in
the ER to the degradation. Understanding of Dg’s cellu-
lar turnover can be useful for targeted manipulation of
Dg protein levels by affecting its specific regulators. To-
gether with Dg, we also co-purified proteins controlling
cellular metabolic processes and factors associated with
mitochondria (Fig. 1e, Additional file 2: Table S1).
Nuclear proteins
Studies in mammalian system suggest that proteolysis,
tyrosine phosphorylation, and translocation of Dg to the
nucleus result in altered gene transcription [110]. A re-
cent study in prostate cancer cells showed cell density-
dependent γ-secretase and furin-mediated proteolysis of
β-dystroglycan which could be stimulated by Notch,
leading to nuclear targeting [111]. Another work uncov-
ered the mechanism of retrograde trafficking of β-
dystroglycan from the plasma membrane to the nucleus
[112]. In immortalized mouse C2C12 myoblasts, after
being synthesized in the ER, α-Dg and β-Dg are trans-
ported from the ER to the Golgi apparatus and then to
the plasma membrane, to form the DGC. The phosphor-
ylation on β-Dg on Tyr890 causes its endocytosis from
the plasma membrane and retrograde intracellular traf-
ficking to the ER and then to the nucleus, mediated by
β-Dg interaction with the Sec61 translocon complex
[112].
In the Drosophila model, nuclear functions of Dg have
not yet been revealed. However, we found Dg to co-
immunoprecipitate with four histone proteins that form
a nucleosome complex (Fig. 1e, Additional file 2: Table
S1). Further dissection of Dg nuclear functions and its
association with nuclear proteins would reveal new regu-
latory mechanisms and show whether Dg’s role to regu-
late nuclear processes is evolutionarily conserved.
Metabolic pathways
Importantly, in the Dg interactome, components from
the glutathione metabolism-controlling pathway and oxi-
dative phosphorylation have been identified. Previously,
we reported that Dg-deficient mutants have impaired
metabolism [39] and that their muscles are particularly
sensitive to dietary restriction [18]. Additionally, we
found that Dg genetically interacts with several mito-
chondrial proteins associated with NADH dehydrogen-
ase activity used in the electron transport chain for the
generation of ATP (Fig. 1d, Additional file 2: Table S1).
Previously, it has been also shown that mutation in the
mitochondrial gene encoding mitochondrial ribosomal
protein LP34 significantly influences Dg phenotypes in
Drosophila [113]. Unfortunately, to date, it is unclear
how Dg influences metabolic processes in muscle cells.
Depending on the metabolic activity, muscles can be
classified into two major classes: type I, which are red in
appearance, slow-twitching, highly oxidative, and
fatigue-resistant; and type II, which are white, fast-
twitching, glycolytic, and quickly fatigable [114]. Our
data show that Dg interacts with cytoplasmic and mito-
chondrial proteins, which could potentially promote type
I muscle fiber mode. Since it has been reported that in
Drosophila flight muscles, glycolytic enzymes are co-
localized along sarcomeres at M-lines and Z-discs and
this co-localization is required for normal flight [115], it
would be interesting in the future to test whether Dg
could serve as a platform for localization of metabolic
enzymes, and perhaps, mitochondria in the muscle cell.
Dg and Hippo signaling
Our results demonstrate that the deregulation of Yki
and Kbr results in muscle maintenance and regeneration
defects resembling sarcopenia and cachexia, implying
that proper functioning of the Hippo pathway in muscles
is required to control muscle size and sustain muscle in-
tegrity in young and aged animals. Therefore, it is im-
portant to study in greater detail the up- and
downstream regulators of this pathway, targeting of
which could ameliorate muscle wasting phenotypes. In
addition, our data show that Dg interacts with both Kbr
and Yki, suggesting that these interactions could fine-
tune the activity of Hippo signaling in the muscles, af-
fecting age-dependent muscle maintenance and regener-
ation (Fig. 7).
The Hippo pathway is linked to the cellular signals
originated from the extracellular environment and trans-
duced inside the cell through the plasma membrane pro-
teins. Therefore, the Hippo pathway scaffolding complex
formed at the membrane may contribute to the activa-
tion of the pathway [28, 70, 116, 117]. Since we found
that Kbr interacts with Dg, we propose that Dg acts as
an additional transmembrane receptor for Hippo signal-
ing. Hippo signaling has been also shown to regulate
myogenesis, myocyte growth, and survival [32, 118–122].
In addition, it controls tissue homeostasis and regener-
ation, organ size, and stem cell self-renewal through the
regulation of cell proliferation, cell communication, and
apoptosis [68–70]. Interestingly, Yap-DAG1 interaction
was enhanced by Hippo-induced Yap phosphorylation;
however, Yap phosphorylation is not required for DAG1
binding in vitro, suggesting that Hippo phosphorylation
of Yap promotes the Yap-DGC complex formation
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in vivo [36]. Yap was also co-immunoprecipitated with
sarcoglycan complex protein, and Yap’s interaction with
the Dg or Sgc was perturbed in mdx (Dys deficient)
mice, suggesting that Dys is required for the Dg-Yap as-
sociation. Interestingly, in vitro binding assays showed
that to sequester Yap, Dg binds Yap’s WW domain by
the C-terminal PPxY-motif [36]. Since Dg association
with the Hippo serine/threonine protein kinase Lats2
(large tumor suppressor kinase 2) which is homologous
to Drosophila Warts was not detected in the co-
immunoprecipitation experiment, the authors suggested
that other Hippo pathway components do not form a
complex with the DGC, just phosphorylated Yap [36]. In
our study, in addition to Yki/Yap, we co-
immunoprecipitated together with Dg another WW
domain-containing Hippo signaling protein, Kbr. Both
proteins, Kbr and Yki, contain two WW binding sites
that can potentially bind Dg’s PPxY motifs. It has also
been previously established that Dg contains two con-
served PPxY motifs at the C-terminal end; both of them
are functional and can mediate interaction with Dys pro-
tein in mammals and flies [13, 19, 71, 72]. Intriguingly, it
has been recently demonstrated that the WW domain of
Kbr, but not YAP, can bind the beta-Dg peptide [74];
therefore, further in vivo studies are necessary to clarify
the mode of Dg interaction with these two Hippo signal-
ing components.
It has been previously shown in mammalian cell cul-
ture that YAP acts as a mechanotransducer, and its nu-
clear localization depends on basal integrin-Src
signaling. Importantly, Src can directly phosphorylate
YAP; however, it remains unclear whether integrin-Src
signaling acts directly on YAP or via the canonical
Hippo signaling pathway [123, 124]. In Drosophila,
mechanical strain directly regulates the Hippo pathway
and no evidence has been found for the involvement of
other pathways, such as Src42A kinase, in the regulation
of Yki [125]. This suggests that in different contexts,
mechanosensing via the Hippo pathway can be
employed to regulate either cell proliferation or cellular
morphogenesis, or simply to help promote apical do-
main homeostasis. We think that the interaction of Dg
with Yki also can be cell- and tissue-dependent. There-
fore, it would be necessary to analyze Yki/Yap regulation
by Dg and integrin/Src in different cell and tissue types
in both vertebrate and invertebrate models to draw clear
conclusions about the extent of Yki regulation by Dg or
integrins. In addition, considering the importance of
post-translational modifications of Dg for its proper
functions, it would be important to study how abnormal
Dg glycosylation would affect its interaction with Hippo
signaling.
Together, our work in Drosophila adult muscles shows
evolutionarily conserved relations between the DGC and
Hippo kinase signaling and suggests that manipulations
of the Hippo signaling pathway could impact the severity
of muscular dystrophy, sarcopenia, and cachexia
syndromes.
Conclusions
Here, we used Drosophila as a genetic model to find
new MD players. We identified the muscle-specific Dg
complexome by mass spectrometry analysis. We identi-
fied Dg to be associated with two components of the re-
cently discovered and conserved Hippo signaling
pathway, the WW domain-containing proteins Kbr and
Yki. We have shown that Dg is important for muscle
maintenance and its functional association with Kbr and
Yki is crucial to adjust Hippo signaling to influence
muscle size and integrity during aging (Fig. 7). Based on
our results, we propose that Dg transmits signals sensed
by the extracellular region to the inside of the cell via
interaction with multiple ECM, membrane-associated,
and cytoskeletal proteins, including Hippo kinase signal-
ing components, which regulate age-dependent muscle
maintenance and regeneration. Importantly, among the
identified Dg-interacting proteins were novel
membrane-associated components, cytoskeletal proteins,
and cytoplasmic and nuclear factors (Fig. 1, Add-
itional file 2: Table S1). Therefore, systematic studies of
Dg function, regulation, and association with other pro-
teins are essential not only for understanding muscle cell
function under constant mechanical stress, but also for
uncovering novel markers for MD diagnostics and devel-
oping innovative possibilities for MD therapeutics.
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